Search

Your search keyword '"Saji, Hisashi"' showing total 483 results

Search Constraints

Start Over You searched for: Author "Saji, Hisashi" Remove constraint Author: "Saji, Hisashi"
483 results on '"Saji, Hisashi"'

Search Results

1. Thoracic and cardiovascular surgeries in Japan during 2021: Annual report by the Japanese Association for Thoracic Surgery

2. Thoracic and cardiovascular surgeries in Japan during 2020: Annual report by the Japanese Association for Thoracic Surgery

3. Thoracic and cardiovascular surgeries in Japan during 2019: Annual report by the Japanese Association for Thoracic Surgery

4. Neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant pembrolizumab compared with neoadjuvant chemotherapy alone in patients with early-stage non-small-cell lung cancer (KEYNOTE-671): a randomised, double-blind, placebo-controlled, phase 3 trial

5. Lymph node dissection in small peripheral lung cancer: Supplemental analysis of JCOG0802/WJOG4607L

6. Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer with radiologically pure-solid appearance in Japan (JCOG0802/WJOG4607L): a post-hoc supplemental analysis of a multicentre, open-label, phase 3 trial

7. Risk Factors for Locoregional Relapse After Segmentectomy: Supplementary Analysis of the JCOG0802/WJOG4607L Trial

12. Segmentectomy for ground-glass-dominant lung cancer with a tumour diameter of 3 cm or less including ground-glass opacity (JCOG1211): a multicentre, single-arm, confirmatory, phase 3 trial

14. Randomized phase II trial of pemetrexed-cisplatin plus bevacizumab or thoracic radiotherapy followed by surgery for stage IIIA (N2) nonsquamous non–small cell lung cancer

16. Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial

17. A Prospective Observational Study on Analyzing Lung Cancer Gene Mutation Variant Allele Frequency (VAF) and Its Correlation with Treatment Efficacy.

21. Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer with radiologically pure-solid appearance in Japan (JCOG0802/WJOG4607L): a post-hoc supplemental analysis of a multicentre, open-label, phase 3 trial

25. Neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant pembrolizumab compared with neoadjuvant chemotherapy alone in patients with early-stage non-small-cell lung cancer (KEYNOTE-671): a randomised, double-blind, placebo-controlled, phase 3 trial

26. Lymph node dissection in small peripheral lung cancer: supplemental analysis of JCOG0802/WJOG4607L

27. Risk factors for loss of pulmonary function after wedge resection for peripheral ground-glass opacity dominant lung cancer

34. Bleeding control.

41. Segmentectomy for ground-glass-dominant lung cancer with a tumour diameter of 3 cm or less including ground-glass opacity (JCOG1211): a multicentre, single-arm, confirmatory, phase 3 trial

42. Early chest tube removal within 6 hours after thoracic surgery results in improved postoperative prognosis and no adverse effects

50. Randomized phase II trial of pemetrexed-cisplatin plus bevacizumab or thoracic radiotherapy followed by surgery for stage IIIA (N2) nonsquamous non–small cell lung cancer

Catalog

Books, media, physical & digital resources